Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Risk-adapted Screening in First-degree Relatives of Patients With Colorectal Cancer (FAMKOL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01903395
Recruitment Status : Completed
First Posted : July 19, 2013
Last Update Posted : October 25, 2016
Sponsor:
Information provided by (Responsible Party):
Alexander Bauer, Martin-Luther-Universität Halle-Wittenberg

Brief Summary:

BACKGROUND: First-degree relatives of patients with colorectal cancer are at increased risk for colorectal cancer as well. Nevertheless, participation in the German national screening program stagnates at 2-3 percent per year even in this high-risk population.

AIM: The study is aimed to increase the portion of the first-degree relatives on 50% which take up a preventive colonoscopy.

METHODS: Cluster-randomized controlled multi-center trial. Study sites (clusters) are mainly certified cancer centers and office-based gastroenterologists from all over Germany. Index-patients with colorectal cancer of different stages are asked to hand over the study material to their relatives, consisting of an invitation to a nurse-led counseling on preventive colonoscopy and an one-to-one appointment with a clinical expert of one of the study sites next.


Condition or disease Intervention/treatment Phase
Colorectal Neoplasms Behavioral: Nurse-led counselling Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 313 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Prevention
Official Title: Nurse-led Colon Cancer Risk Counseling for First-degree Relatives to Enhance Use of Colonoscopy
Study Start Date : March 2012
Actual Primary Completion Date : December 2015
Actual Study Completion Date : December 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Nurse-led counselling
First-degree relatives of patients undergoing active treatment for colorectal cancer are offered a nurse-led counselling by telephone regarding emotional and cognitive barriers to screening utilization.
Behavioral: Nurse-led counselling
Nurse-led telephone counselling to double the utilization of preventive colonoscopy

No Intervention: Usual Care
Usual print media, offered standardly by the recruiting centres.



Primary Outcome Measures :
  1. utilization of preventive colonoscopy [ Time Frame: utilization within 30 days after enrolement ]

Secondary Outcome Measures :
  1. Rate of advanced adenomas or carcinomas in situ [ Time Frame: Rate within 6 month after enrolement ]
  2. post-operative complications associated with the colonoscopy [ Time Frame: within 30 days after enrolement ]
  3. barriers to the use of preventive colonoscopy [ Time Frame: within 30 day after enrolement, additional at 6 months after enrolement ]

    Barriers against preventive colonoscopy are very common among the healthy population. Such barriers can bei either of cognitive (e.g. being afraid of the potential diagnosis) or emotional nature (e.g. shame to be exposed naked to the examiners).

    Barriers are assessed by Barriers Questionnaire-II (BQ-II) during telephone counselling.


  4. effectiveness and cost-effectiveness of nurse-led counselling [ Time Frame: within 30 days after enrolement ]
  5. time delay between signed informed consent and utilization of colonoscopy [ Time Frame: at utilization of the colonoscopy ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   45 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • aged 18 and over
  • being first-degree relatives of patients with diagnosed colorectal cancer
  • able to understand German

Exclusion Criteria:

  • Familial Adenomatous Polyposis
  • utilization of diagnostic colonoscopy within the past 5 years
  • being ever treated for colorectal cancer
  • actual inflammatory bowl disease
  • comorbidities associated with reduced further life expectancy (ECOG performance status >3

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01903395


Locations
Layout table for location information
Germany
Klinikum Ludwigsburg
Ludwigsburg, Baden-Würtemberg, Germany, 71640
Diakoniekrankenhaus Mannheim
Mannheim, Baden-Würtemberg, Germany, 68163
Klinikum Stuttgart Krankenhaus Bad Cannstatt
Stuttgart, Baden-Würtemberg, Germany, 70374
Universitätsklinikum Ulm
Ulm, Baden-Würtemberg, Germany, 89081
Kliniken Landkreis Sigmaringen GmbH
Sigmaringen, Baden-Württemberg, Germany, 72488
Klinikum Aschaffenburg
Aschaffenburg, Bayern, Germany, 63739
Universitätsklinikum Erlangen
Erlangen, Bayern, Germany, 91054
Stiftung Juliusspital Würzburg
Würzburg, Bayern, Germany, 97070
Klinikum Barnim
Eberswalde, Brandenburg, Germany, 16225
Klinikum Hanau
Hanau, Hessen, Germany, 63450
Universitätsklinikum Gießen und Marburg
Marburg, Hessen, Germany, 35043
HELIOS Kliniken Schwerin
Schwerin, Mecklenburg-Vorpommern, Germany, 19049
Städtisches Klinikum Braunschweig
Braunschweig, Niedersachsen, Germany, 38126
Allgemeines Krankenhaus Celle
Celle, Niedersachsen, Germany, 29223
Städtisches Klinikum Lüneburg
Lüneburg, Niedersachsen, Germany, 21339
Klinikum Osnabrück GmbH
Osnabrück, Niedersachsen, Germany, 49076
Johanniter-Krankenhaus Rheinhausen
Duisburg, Nordrhein-Westfalen, Germany, 47228
Sankt Elisabeth Hospital Gütersloh
Gütersloh, Nordrhein-Westfalen, Germany, 33332
Krankenhaus Köln-Holweide
Köln, Nordrhein-Westfalen, Germany, 51067
Klinik Evang. Krankenhaus Kalk
Köln, Nordrhein-Westfalen, Germany, 51103
Klinikum Lüdenscheid
Lüdenscheid, Nordrhein-Westfalen, Germany, 58515
Universitätsklinikum Knappschaftskrankenhaus Ruhr Universität Bochum
Bochum, Nordrhein-Wetsfalen, Germany, 44892
Krankenhaus St. Marienwörth
Bad Kreuznach, Rheinland-Pfalz, Germany, 55543
Diakonissen-Stiftungs-Krankenhaus Speyer
Speyer, Rheinland-Pfalz, Germany, 67346
Gastroenterologische Schwerpunktpraxis Völklingen
Völklingen, Saarland, Germany, 66333
Diakonissenkrankenhaus Dessau gemeinnützige GmbH
Dessau-Roßlau, Sachsen-Anhalt, Germany, 06846
Evangelisches Krankenhaus Paul Gerhardt Stift
Lutherstadt Wittenberg, Sachsen-Anhalt, Germany, 06886
Praxis für Innere Medizin Dr. med. Regine Lange
Lutherstadt Wittenberg, Sachsen-Anhalt, Germany, 06886
Klinikum Magdeburg gemeinnützige GmbH
Magdeburg, Sachsen-Anhalt, Germany, 39130
HELIOS Klinik Sangerhausen
Sangerhausen, Sachsen-Anhalt, Germany, 06526
Evangelisches Diakonissenkrankenhaus Leipzig gGmbH
Leipzig, Sachsen, Germany, 04177
Westküstenklinikum Heide
Heide, Schleswig-Holstein, Germany, 25746
Universitätsklinikum Jena
Jena, Thüringen, Germany, 07747
Sponsors and Collaborators
Martin-Luther-Universität Halle-Wittenberg
Investigators
Layout table for investigator information
Principal Investigator: Alexander Bauer, PhD Martin-Luther-University Halle-Wittenberg, Medical Faculty, Institute for Health and Nursing Science

Layout table for additonal information
Responsible Party: Alexander Bauer, PhD, Martin-Luther-Universität Halle-Wittenberg
ClinicalTrials.gov Identifier: NCT01903395     History of Changes
Other Study ID Numbers: NKP332-032
First Posted: July 19, 2013    Key Record Dates
Last Update Posted: October 25, 2016
Last Verified: October 2016

Keywords provided by Alexander Bauer, Martin-Luther-Universität Halle-Wittenberg:
Colorectal Neoplasms/*drug therapy/*secondary
Health Services Accessibility
Humans
Supportive Care Needs
Psychooncology
Primary Health Care/*methods
Treatment Outcome
Socioeconomic Factors
Quality Assurance, Health Care
Adult
Aged
Aged, 80 and over

Additional relevant MeSH terms:
Layout table for MeSH terms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases